Research Article

ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer

Figure 5

EMT contributes to ERO1L-mediated hepatic metastasis of PDAC. (a) Down reg () and otherwise () were divided, based on the rate of ERO1L expression in hepatic metastasis and primary tumor. (b) The relatively lower ERO1L expression in hepatic metastasis leading to the lower activity of EMT. (c) GSEA suggesting lower ERO1L expression in hepatic metastasis would remarkably inhibit the activity of EMT pathway and whereas improve the activity of G2M CHECPIONT pathway positively correlated with pancreatic cancer metastasis. (d) Western blotting analysis of Capan-2 and MiaPaCa-2 cells after inhibiting ERO1L expression with shRNAs and EN460.
(a)
(b)
(c)
(d)